Natural killer cell membrane infused biomimetic liposomes for targeted tumor therapy. (April 2018)

• Record Type: Journal Article
• Authors: Pitchaimani, Arunkumar; Nguyen, Tuyen Duong Thanh; Aryal, Santosh
• Is Part Of: Biomaterials. Volume 160(2018)
• Page Start: 124
• Page End: 137
• Publication Date: 2018-04
• Subjects: Biomimetic -- Natural killer cells -- Cell membrane -- Fusogenic liposomes -- Doxorubicin -- Tumor therapy; Biomedical materials -- Periodicals; Biocompatible Materials -- Periodicals; Biomatériaux -- Périodiques; 610.28
• DOI: 10.1016/j.biomaterials.2018.01.018
• Languages: English
• ISSNs: 0142-9612

Abstract

Abstract: Therapeutic efficacy of a systemic drug delivery largely depends on the targeting design of the delivery system, which tackles with circulatory traffic and prevents the nonspecific distribution of the drug in the wide range of vital organs. A drawing attention has been given to a biomimetic cloaking of the synthetic drug delivery nanoparticle using mammalian cell-ghosts, which has shown the installment of the biological complexity of the original cells thereby acting as naïve cells, to precisely delivery drug to the intended target. Align towards this direction; we developed a membrane camouflage fusogenic liposomal delivery system "NKsome" for targeted tumor therapy using Natural Killer (NK) cell-ghost, which naturally undergoes immunosurveillance of diseased/stress cells. The engineered NKsome shows successful retention of NK cell membrane-associated targeting protein on its surface. With its excellent biocompatibility, NKsome shows a higher affinity towards cancer than normal cells as demonstrated by in vitro flow-passage assay, and exhibits enhanced tumor homing efficiency in-vivo with an extended plasma residence time of 18 h. Moreover, the therapeutic potential of doxorubicin-loaded NKsome shows promising antitumor activity in vivo against MCF-7 induced tumor model. Overall results illustrate the therapeutic advantages of NK cell biomimicry capable of communicating like immune cells for cooperative drug delivery. Graphical abstract: Natural killer cell membrane infused biomimetic liposomes for targeted tumor therapy.